Literature DB >> 6341583

Prostacyclin.

J R Vane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6341583      PMCID： PMC1438970          DOI： 10.1177/014107688307600401

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  49 in total

1.  THE ENZYMATIC FORMATION OF PROSTAGLANDIN E2 FROM ARACHIDONIC ACID PROSTAGLANDINS AND RELATED FACTORS 32.

Authors:  S BERGSTROEM; H DANIELSSON; B SAMUELSSON
Journal:  Biochim Biophys Acta       Date:  1964-07-15

2.  Prostacyclin deficiency in thrombotic thrombocytopenic purpura.

Authors:  C N Hensby; P J Lewis; P Hilgard; G J Mufti; J Hows; J Webster
Journal:  Lancet       Date:  1979-10-06       Impact factor: 79.321

3.  Stimulation of human foreskin fibroblast adenosine 3':5'-cyclic monophosphate levels by prostacyclin (prostaglandin I2).

Authors:  R R Gorman; R D Hamilton; N K Hopkins
Journal:  J Biol Chem       Date:  1979-03-10       Impact factor: 5.157

Review 4.  Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis.

Authors:  S Moncada; J R Vane
Journal:  Br Med Bull       Date:  1978-05       Impact factor: 4.291

5.  Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.

Authors:  P J Piper; J R Vane
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

6.  Introduction of a nomenclature: leukotrienes.

Authors:  B Samuelsson; P Borgeat; S Hammarström; R C Murphy
Journal:  Prostaglandins       Date:  1979-06

7.  The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.

Authors:  F B Ubatuba; S Moncada; J R Vane
Journal:  Thromb Haemost       Date:  1979-04-23       Impact factor: 5.249

8.  Prostacyclin can replace heparin in haemodialysis in dogs.

Authors:  H F Woods; G Ash; M J Weston; S Bunting; S Moncada; J R Vane
Journal:  Lancet       Date:  1978-11-18       Impact factor: 79.321

9.  Successful therapy of advanced arteriosclerosis obliterans with prostacyclin.

Authors:  A Szczeklik; R Nizankowski; S Skawinski; J Szczeklik; P Gluszko; R J Gryglewski
Journal:  Lancet       Date:  1979-05-26       Impact factor: 79.321

10.  Effects of some naturally occurring prostaglandins of the D-, E-, and I-type and synthetic analogues on adenylate cyclase of human fat cell ghosts.

Authors:  H Kather; B Simon
Journal:  Res Exp Med (Berl)       Date:  1979-10
View more
  3 in total

1.  Apolipoprotein E favours the blunting by high-fat diet of prostacyclin receptor activation in the mouse aorta.

Authors:  Yanhua Cheng; Paul M Vanhoutte; Susan W S Leung
Journal:  Br J Pharmacol       Date:  2018-07-22       Impact factor: 8.739

2.  Use of prostacyclin and ultrafiltration in adult respiratory distress syndrome.

Authors:  A Richardson; F C Wells; M A Branthwaite
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

Review 3.  Benefit-Risk Assessment of Fish Oil in Preventing Cardiovascular Disease.

Authors:  Bill Lands
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.